Axiom Investors’s Omnicell OMCL Stock Holding History

Axiom Investors’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,915	Closed	-$903K	–	136
2022 Q4	$903K	Sell	17,915 -1,335	-7%	-$80.2K	0.02%	116
2022 Q3	$1.68M	Sell	19,250 -37,010	-66%	-$3.89M	0.04%	111
2022 Q2	$6.4M	Buy	56,260 +5,735	+11%	+$658K	0.19%	66
2022 Q1	$6.54M	Sell	50,525 -9,120	-15%	-$1.31M	0.15%	69
2021 Q4	$10.8M	Buy	59,645 +4,821	+9%	+$836K	0.2%	63
2021 Q3	$8.14M	Buy	54,824 +8,022	+17%	+$1.23M	0.13%	74
2021 Q2	$7.09M	Buy	46,802 +3,534	+8%	+$492K	0.11%	78
2021 Q1	$5.62M	Buy	+43,268	New	+$5.55M	0.1%	88
2019 Q4	–	Sell	-12,278	Closed	-$887K	–	127
2019 Q3	$887K	Sell	12,278 -41,177	-77%	-$3.02M	0.02%	113
2019 Q2	$4.6M	Buy	53,455 +14,997	+39%	+$1.22M	0.13%	72
2019 Q1	$3.11M	Sell	38,458 -40,640	-51%	-$3.04M	0.1%	83
2018 Q4	$4.84M	Buy	79,098 +6,945	+10%	+$470K	0.17%	70
2018 Q3	$5.19M	Buy	72,153 +47,733	+195%	+$3.01M	0.15%	80
2018 Q2	$1.28M	Sell	24,420 -18,500	-43%	-$870K	0.04%	136
2018 Q1	$1.86M	Sell	42,920 -98,298	-70%	-$4.52M	0.05%	124
2017 Q4	$6.85M	Sell	141,218 -2,760	-2%	-$139K	0.17%	74
2017 Q3	$7.35M	Buy	143,978 +43,508	+43%	+$2.08M	0.17%	82
2017 Q2	$4.33M	Buy	100,470 +31,102	+45%	+$1.29M	0.1%	94
2017 Q1	$2.82M	Buy	69,368 +6,699	+11%	+$247K	0.07%	105
2016 Q4	$2.12M	Sell	62,669 -11,170	-15%	-$384K	0.06%	126
2016 Q3	$2.83M	Sell	73,839 -34,098	-32%	-$1.27M	0.08%	68
2016 Q2	$3.69M	Buy	107,937 +12,815	+13%	+$400K	0.11%	82
2016 Q1	$2.65M	Buy	95,122 +41,456	+77%	+$1.14M	0.08%	98
2015 Q4	$1.67M	Buy	+53,666	New	+$1.58M	0.05%	110
2015 Q1	–	Sell	-91,680	Closed	-$3.04M	–	155
2014 Q4	$3.04M	Buy	91,680 +25,194	+38%	+$778K	0.08%	90
2014 Q3	$1.82M	Buy	66,486 +18,386	+38%	+$504K	0.05%	111
2014 Q2	$1.38M	Buy	+48,100	New	+$1.3M	0.03%	129

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Axiom Investors's OMCL Position: Q1 2023 in Review

Axiom Investors sold out of Omnicell (OMCL) in Q1 2023, closing a stake of 17,915 shares — an estimated $903K sold.

Axiom Investors first reported a position in OMCL in Q2 2014 and held it in 27 quarters. The position peaked at $10.8M in Q4 2021. 318 funds tracked by Wall St. Rank hold OMCL as of Q1 2023.

Axiom Investors reported no remaining Omnicell position as of Q1 2023 after selling out during the quarter.
Axiom Investors sold 17,915 Omnicell shares in Q1 2023, an estimated $903K.
Axiom Investors first reported a position in Omnicell in Q2 2014 and held it in 27 quarters.
Axiom Investors's Omnicell position peaked at $10.8M in Q4 2021.
318 funds tracked by Wall St. Rank held Omnicell as of Q1 2023.

Based on Axiom Investors's 13F filing for Q1 2023, filed 12 May 2023.